UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Palbociclib in combination with letrozole as first or later line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

Annals of oncology, 2018-10, Vol.29, p.viii111-viii111

2018

Volltextzugriff (PDF)

371PPalbociclib plus fulvestrant as second- or later-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1552PPatients with metastatic non-small cell lung cancer and targetable molecular alterations in Germany. Treatment and first outcome data from the prospective German Registry Platform CRISP (AIO-TRK-0315)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1519PPatients with metastatic non-small cell lung cancer and PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

341PPalbociclib in combination with letrozole as first or later line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

969PAdvanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1500PPatients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide

European journal of cancer & clinical oncology, 1991-01, Vol.27 (9), p.1137-1140

1991

Volltextzugriff (PDF)

OT3-01-04: TANIA: A Randomized Phase III Trial Evaluating Continued and Reintroduced Bevacizumab (BEV) in Patients Previously Treated with 1st-Line BEV for Locally Recurrent/Metastatic Breast Cancer (LR/mBC)

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.OT3-01-04-OT3-01-04

2011

Volltextzugriff (PDF)

Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution

Progress in experimental tumor research, 1992, Vol.34, p.131

1992

Volltextzugriff (PDF)

Determination of alkylphosphocholines and of alkyl-glycero-phosphocholines in biological fluids and tissues

Progress in experimental tumor research, 1992, Vol.34, p.6

1992

Volltextzugriff (PDF)

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients

Annals of oncology, 2011-03, Vol.22 (3), p.595

2011

Volltextzugriff (PDF)

Long-term results of the anti-emetic effectiveness of the 5-HT3 antagonist ondansetron

Onkologie, 1990-08, Vol.13 (4), p.313

1990

Volltextzugriff (PDF)

Hexadecylphosphocholine and Octadecyl-methyl-glycero-3-phosphocholine: A Comparison of Hemolytic Activity, Serum Binding and Tissue Distribution

1992

Volltextzugriff (PDF)

MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation

Leukemia, 2017-12, Vol.31 (12), p.2732-2741

2017

Volltextzugriff (PDF)

Recent advances of PET imaging in clinical radiation oncology

Radiation oncology (London, England), 2020-04, Vol.15 (1), p.88-15, Article 88

2020

Volltextzugriff (PDF)

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

The Lancet (British edition), 2015-04, Vol.385 (9976), p.1397-1405

2015

Volltextzugriff (PDF)

Delayed versus Immediate Cord Clamping in Preterm Infants

The New England journal of medicine, 2017-12, Vol.377 (25), p.2445-2455

2017

Volltextzugriff (PDF)

Knowledge Updates 2020/3

1st edition, 2020

Volltextzugriff (PDF)

Ensuring planetary survival: the centrality of organic carbon in balancing the multifunctional nature of soils

Critical reviews in environmental science and technology, 2022-12, Vol.52 (23), p.4308-4324

2022

Volltextzugriff (PDF)

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

Annals of oncology, 2003-12, Vol.14 (12), p.1735-1743

2003

Volltextzugriff (PDF)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

The Lancet (British edition), 2012-08, Vol.380 (9841), p.581-590

2012

Volltextzugriff (PDF)

The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer

Annals of surgical oncology, 2020-07, Vol.27 (7), p.2506-2515

2020

Volltextzugriff (PDF)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

The Lancet (British edition), 2010-11, Vol.376 (9753), p.1670-1681

2010

Volltextzugriff (PDF)

Addition of organic matter influences pH changes in reduced and oxidised acid sulfate soils

Geoderma, 2016-01, Vol.262, p.125-132

2016

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(33)
Humans
(25)
Female
(19)
Oncology
(18)
Male
(12)
Middle Aged
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Adult
(9)
Aged
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Physical Sciences
(8)
Chemotherapy
(7)
Treatment Outcome
(7)
Tumors
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(6)
Breast Neoplasms - Drug Therapy
(6)
Exact Sciences And Technology
(6)
General & Internal Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Palbociclib in combination with letrozole as first or later line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

371PPalbociclib plus fulvestrant as second- or later-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

1552PPatients with metastatic non-small cell lung cancer and targetable molecular alterations in Germany. Treatment and first outcome data from the prospective German Registry Platform CRISP (AIO-TRK-0315)

1519PPatients with metastatic non-small cell lung cancer and PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)

341PPalbociclib in combination with letrozole as first or later line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study

969PAdvanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany

1500PPatients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)

Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide

OT3-01-04: TANIA: A Randomized Phase III Trial Evaluating Continued and Reintroduced Bevacizumab (BEV) in Patients Previously Treated with 1st-Line BEV for Locally Recurrent/Metastatic Breast Cancer (LR/mBC)

Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution

Determination of alkylphosphocholines and of alkyl-glycero-phosphocholines in biological fluids and tissues

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients

Long-term results of the anti-emetic effectiveness of the 5-HT3 antagonist ondansetron

Hexadecylphosphocholine and Octadecyl-methyl-glycero-3-phosphocholine: A Comparison of Hemolytic Activity, Serum Binding and Tissue Distribution

MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation

Recent advances of PET imaging in clinical radiation oncology

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

Delayed versus Immediate Cord Clamping in Preterm Infants

Knowledge Updates 2020/3

Ensuring planetary survival: the centrality of organic carbon in balancing the multifunctional nature of soils

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Addition of organic matter influences pH changes in reduced and oxidised acid sulfate soils

Suchergebnisse filtern